Back to News
Market Impact: 0.3
GSK to shut vaccine factory in Germany, putting 641 jobs at risk
Source: reuters.com
Healthcare & BiotechM&A & Restructuring
GSK will shut its Dresden, Germany vaccine factory in summer 2027. The site produces influenza and hepatitis vaccines, making the closure a negative operational restructuring development that could affect GSK's vaccine manufacturing footprint and local supply capacity.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
GSK-0.50
More News
- Hansoh and GSK drug extends survival in bone cancer study
- Artiva halts AlloNK development, cuts 94% of workforce
- Why is Artiva Biotherapeutics stock collapsing today?
- Bending Spoons Seeks $1.5 Billion in Debt to Fund Acquisitions
- Baldwin Group reports Q3 revenue up 31% to $480.3 million
- Moderna shares slip as William Blair cuts rating on valuation after rally